Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acute disseminated encephalomyelitis
afebrile
ANA
anti Hu antibody
anti Ma
anti MAG antibodies
anti Ri antibody
anti Yo antibody
antibodies to myelin basic protein
antimyelin antibodies
aphasia
areflexia
ascending paralysis
ataxia
ataxia, truncal
ataxic gait
athetosis
atypical
autoantibodies
autoimmune disease
basal ganglia, lesion of
basal ganglia, lesion, bilateral
brachial neuritis
brainstem, lesion of
brainstem, surface lesion of, hyperintense
carcinoma
carcinoma of breast
carcinoma of lung
carcinoma of ovary
central vein sign
cerebellar lesion
cerebellar peduncle
cerebellum
cerebral cortex
cerebral cortical encephaliis
cerebrospinal fluid
cerebrospinal fluid, abnormal
cerebrospinal fluid, elevated protein of
children
chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids
comorbidities
confusion
confusional state, acute
conus medullaris, lesion of
cranial nerve palsies
deep gray nuclei
demyelinating disease
diagnostic criteria
differential diagnosis
diplopia
disability, neurological
drowsiness
dysarthria
echolalia
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalomyelitis
encephalopathy
encephalopathy, progressive
eye movement, painful
eye, pain in
false positive
familial
fever
FLAMES
gait disorder
GALOP syndromes
gyrus, abnormal
headache
heralding manifestation
hiccoughs
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
H-sign, spinal cord
idiopathic
imbalance
immunologic disease
immunomodulation
immunosuppressive agents
infection
limbic encephalitis
memory, defect of recent
memory, impairment of
meningeal enhancement
middle cerebellar peduncle
middle cerebellar peduncle, lesion
middle cerebellar peduncle, lesion, bilateral
mimics
misdiagnosis
monoclonal gammopathy
movement disorder
MRI
MRI pattern
MRI, abnormal
MRI, contrast enhanced
MRI, contrast enhanced, cloud-like
MRI, cortical enhancement
MRI, diffusion weighted
MRI, disappearing lesion on
MRI, FLAIR
MRI, gyral enhancement
MRI, optic nerve
MRI, serial
MRI, spinal cord
multiple sclerosis
multiple sclerosis, children
multiple sclerosis, clinical patterns
multiple sclerosis, diagnosis of
multiple sclerosis, monosymptomatic
multiple sclerosis, prognosis
multiple sclerosis, tumefactive
myasthenic syndrome
myelitis
myelitis, longitudinal
myelitis, transverse
myelitis, transverse, idiopathic
myelopathy
myelopathy, ischemic
myopathy
nausea and vomiting
nerve conduction studies
neuroinfectious diseases
neurologic disease
neurologic disease, diagnoses of
neurologic disease, multiple
neurologic examination, focal
neuromuscular junction, abnormality of
neuromyelitis optica (Devic's disease)
neuromyelitis optica spectrum disorder
neuromyelitis optica, IgG
neuropathology
neuropathy
neuropathy, chronic
neuropathy, demyelinating
neuropathy, peripheral, treatment
NMDA antagonists
old age, neurology of
opsoclonus
opsoclonus-myoclonus syndrome
optic disc edema
optic nerve sheath enhancement
optic nerve, enlarged
optic nerve, lesion of
optic neuritis
optic neuritis, bilateral
optic neuritis, recurrent
optical coherence tomography
overlap syndrome
pain
pain, back
paraparesis, flaccid
paraproteinemia
paresthesias
paresthesias, feet
paresthesias, hands
paroxysmal neurologic disorder
perineuritis
perineuritis, optic
pleocytosis of cerebrospinal fluid
pleocytosis of cerebrospinal fluid, neutrophilic
POEMS syndrome
polyneuropathy
pons, lesion of
posterior leukoencephalopathy syndrome
pregnancy, neurologic complications in
prognosis
progressive neurologic disorder
psychiatric problems in neurologic disorders
Purkinje cell
quadriparesis
recurrent
Red flags
remote effect of cancer on the nervous system
respirator
respiratory failure
review article
rituximab
sarcoidosis, CNS
screening
seizure
seizure, children
seizure, focal
sensory level
serologic testing
serologic testing of cerebrospinal fluid
seronegative
seropositive
spinal cord, compression of
spinal cord, lesion of
strokelike episodes
thalamus, lesion of
thalamus, lesion of-bilateral
thymoma
treatment of neurologic disorder
tumefactive lesion
urinary retention
vision loss, sequential
vision, blurred
visual loss
visual loss, progressive
visual loss, sudden
water channel antibodies
weakness
weakness, generalized
white matter disease
workup
Showing articles 450 to 500 of 1714 << Previous Next >>

Autoimmune limbic encephalitis: an expanding concept
, Moll, J.W.,et al, 2009

Long-Term Course of Demyelinating Neuropathies Occurring During Tumor Necrosis Factor-a-Blocker Therapy
JAMA Neurol 66:490-497, Lozeron, P.,et al, 2009

Neuro-Ophthalmologic Manifestations of Paraneoplastic Syndromes
J Neuro-Ophthalmol 28:58-68, Ko,M.W.,et al, 2008

Plasma Exchange for Anti GAD Associated Non Paraneoplastic Limbic Encephalitis
Transfus Apher Sci 39:229-233, Mazzi,G.,et al, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Non-Paraneoplastic Limbic Encephalitis Associated with Anti-Glutamic Acid Decarboxylase Antibodies
J Neuroimmunol 199:155-159, Mata,S.,et al, 2008

Spectrum of Neurological Syndromes Associated with Glutamic Acid Decarboxylase Antibodes: Diagnostic Clues for this Association
Brain 131:2553-2563, Saiz,A., et al, 2008

Clinicopath Conf, Atypical Carcinoid Tumor with Limbic Encephalitis
NEJM 359:2155-2164, Case 35-2008, 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

Recurrent Guillain-Barr� Syndrome
JNNP 80:56-59, Kuitwaard,K.,et al, 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Response of Anti-NMDA Receptor Encephalitis Without Tumor to Immunotherapy Including Rituximab
Neurol 71:1921-1923, Ishiura,H.,et al, 2008

Anti-Ma and Anti-Ta Associated Paraneoplastic Neurological Syndromes: 22 Newly Diagnosed Patients and Review of Previous Cases
JNNP 79:767-773,742, Hoffmann,L.A.,et al, 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Treatment-Responsive Subacute Limbic Encephalitis and NMDA Receptor Antibodies in a Man
Neurol 70:728-729, Novillo-Lopez,M.E.,et al, 2008

Lymphomatoid Granulomatosis Involving Central Nervous System Successfully Treated With Rituximab alone
Arch Neurol 65:662-665, Ishiura,H.,et al, 2008

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

The Writing on the Wall
Lancet 372:344, Wilder-Smith,E.P. &Ng,E.S., 2008

Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008

Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008

Clinicopath Conf., Anti-MNDAR Antibody Mediated Paraneoplastic Limbic Encephalitis Associated With Ovarian Teratoma
NEJM 359:842-853, Case 26-2008, 2008

Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008

Opsoclonus-Myoclonus-Ataxia Syndrome with Autoantibodies to Glutamic Acid Decarboxylase
Clin Neurol Neurosurg 110:619-621, Markakis,I.,et al, 2008

Auto-Immune Cerebellar Ataxia with Anti-GAD Antibodies Accompanied by De Novo Late-Onset Type 1 Diabetes Mellitus
Diabetes Metab 34:386-388, Bayreuther,C.,et al, 2008

A case of rheumatoid arthritis complicated by demyelination in both cerebral cortex and spinal cord during etanercept therapy
Mod Rheumatol 18:399-402, Kameda, T.,et al, 2008

Nonvasculitic Autoimmune Inflammatory Meningoencephalitis as a Cause of Potentially Reversible Dementia
JNS 108:1024-1027, Lyons, M.,et al, 2008

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008

Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome Without Tumor Removal
Neurol 70:504-511,500, Iizuka,T.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

Mysterious Falls and a Nasal Voice
Lancet 370:712, Bhandari,A. &Adenwalla,F., 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

The Incidence and Significance of Anti-Natalizumab Antibodies: Results from AFFIRM and SENTINEL
Neurol 69:1391-1403,1396, Calabresi,P.A.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Continuous Spectrum of Pharyngeal-Cervical-Brachial Variant of Guillain-Barr� Syndrome
Arch Neurol 64:1519-1523, Nagashima,T.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Quantifying the Risks and Benefits of Natalizumab in Relapsing Multiple Sclerosis
Neurol 68:1524-1528, Dorsey,E.R.,et al, 2007

MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007

Refractory Neurosarcoidosis Responsive to Infliximab
Pract Neurol 7:112-115, Kobylecki,C. &Shaunak,S., 2007

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Post-Transplant Acute Limbic Encephalitis: Clinical Features and Relationship to HHV6
Neurol 69:156-165, Seeley,W.W.,et al, 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

Intravenous Immunoglobulin Therapy for Miller Fisher Syndrome
Neurol 68:1144-1146, Mori,M.,et al, 2007

Autoimmune Limbic Encephalitis in 39 Patients: Immunophenotypes and Outcomes
JNNP 78:381-385,332, Bataller,L.,et al, 2007

Bilateral Ocular Paralysis: Analysis of 31 Inpatients
Arch Neurol 64:178-180, Keane,J.R., 2007

Limbic Encephalitis as a Precipitating Event in Adult-Onset Temporal Lobe Epilepsy
Neurol 69:1236-1244, Bien,C.G.,et al, 2007

Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Neurologist 13:261-271, Tuzun,E. &Dalmau,J., 2007

Clinicopath Conf., Paraneoplastic Cerebellar Degeneration Due to Anti-Yo Antibodies From Breast Cancer
NEJM 356:612-620, Case 4-2007, 2007



Showing articles 450 to 500 of 1714 << Previous Next >>